13 February 2025
Microsaic Systems plc
("Microsaic" or the "Company")
Change of Name Effective
Further to the announcement made on 12 December 2024, Microsaic Systems plc (AIM: MSYS), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, confirms the change of its name to:
Metir plc
Companies House issued a change of name certificate on 11 February 2025 and the name change to Metir plc has become effective immediately. The Company confirms that the change of name has been notified to the London Stock Exchange and trading in the Company's shares under the new company name and new ticker symbol 'AIM:MET' is expected to commence tomorrow (14 February 2025) at 8.00 a.m.
The Company's ISIN (GB00BMWC8365) and SEDOL (BMWC836) will remain unchanged. Shareholders are unaffected by the change of name and existing share certificates should be retained and will remain valid.
In conjunction with the change of name, the Company's website address has changed to www.metirplc.com.
| Metir plc (formerly Microsaic Systems plc) Bob Moore, Acting Executive Chairman | +44 (0) 20 3657 0050 via TPI |
|
|
|
| Singer Capital Markets (Nominated Adviser) Alex Bond / Oliver Platts | +44 (0)20 7496 3000 |
|
|
|
| Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
About Microsaic Systems
Microsaic is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has recently acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities.
Microsaic's products and solutions are commercially available through global markets via a network of regional and country specific distributors and partners.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.